- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 36.27M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 36.15M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 35.83M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2.73M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.88M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.79M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$7.09M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $473.98M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $473.65M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $31.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $40.67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$5.35M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.54M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $31M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $40.5M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $70.46M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $73.54M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $635.86M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $647.27M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $41.99M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $53M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $630.51M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $649.81M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.23 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.27 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.23 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.27 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $25.11M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $26.94M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$8.15M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$9.77M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $2.35M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $738K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $5.05M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $4.93M |
| Revenue | Q1 2026 · Mar 31, 2026 | $74.42M |
| Revenue | Q1 2026 · Mar 31, 2025 | $75.06M |